Article
Immune Responses to AAV in Clinical Trials
2011-06-20
Abstract excerpt
Findings in the first clinical trial in which an adeno-associated virus (AAV) vector was introduced into the liver of human subjects highlighted an issue not previously identified in animal studies. Upon AAV gene transfer to liver, two subjects developed transient elevation of liver enzymes, likely as a consequence of immune rejection of transduced hepatocytes mediated by AAV capsid-specific CD8+ T cells. Studies...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2aa93c27-a8ff-590d-a2d3-8acfc861eb0e
- DOI
- 10.2174/156652311796150354
